Prediction of cancer outcome with microarrays: a multiple random validation strategy.
By S. Michiels, S. Koscielny, C. Hill. The Lancet, 2005
1,040 citations recorded by the source corpus.
Subfields: Cancer Research, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/1ef84899fbd136a17d08cbaa4baded5c4997e8d6
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
- Naftali Kaminski
- Eran Segal
- Douglas G. Altman
- Aviv Regev
- Jan Lemeire
- Alexander R. Statnikov
- Jill P. Mesirov
- Daphne Koller
In Molecular Biology
- Aviv Regev
- Verónica Bolón-Canedo
- Amparo Alonso-Betanzos
- Yujin Hoshida
- Nir Friedman
- Noelia Sánchez-Maroño
- Arul M. Chinnaiyan
- Eran Segal
Citations in the corpus
- Google Goes Cancer: Improving Outcome Prediction for Cancer Patients by Network-Based Ranking of Marker Genes (2012, methodology): “To get a robust estimate on the classification error rate, we adopted the multiple random validation strategy described by [22].”
- Gene Expression-Based Classification of Non-Small Cell Lung Carcinomas and Survival Prediction (2010, background): “It has been noted before that there is very little, if any, overlap between the reported prognostic signatures for NSCLC [25,31].”
- Algorithms for Discovery of Multiple Markov Boundaries (2013, methodology): “Description: In resampling-based methods, multiple variable sets are extracted by repeatedly applying a variable selection method to different bootstrap samples of the data (Ein-Dor et al., 2005; Michiels et al., 2005; Roepman et al., 2006; Statnikov and Aliferis, 2010a).”
- A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus (2008, background): “…results obtained by different laboratories and across platforms raised suspicion about the validity of these results, and this remains a major concern (Bammler et al., 2005; Frantz, 2005; Ioannidis, 2005; Irizarry et al., 2005; Larkin et al., 2005; Michiels et al., 2005; Shi et al., 2006).”
- Machine learning applications in cancer prognosis and prediction (2014, background): “Various aspects regarding the prediction of cancer outcome based on gene expression signatures are discussed in [8,9].”
- A review of microarray datasets and applied feature selection methods (2014, background): “For example, in [82] it is reported that reanalysis of data from the seven largest published microarray-based studies that have attempted to predict the prognosis of cancer patients reveals that five of those seven did not classify patients better than chance.”
- The balance of reproducibility, sensitivity, and specificity of lists of differentially expressed genes in microarray studies (2008, background): “Criticism of and concerns about microarrays continue to appear in some of the most prestigious scientific journals [6-10], leading to a growing negative perception regarding microarray reproducibility, and hence reliability.”
- The Influence of Feature Selection Methods on Accuracy, Stability and Interpretability of Molecular Signatures (2011, background): “Independently of differences in cohorts or technologies, [3] and [4] demonstrate that a major cause for the lack of overlap between signatures is that many different signatures lead to similar predictive accuracies, and that the process of estimating a signature is very sensitive to the samples used”
- Subclass Mapping: Identifying Common Subtypes in Independent Disease Data Sets (2007, background): “DNA microarray-based whole genome expression profiling is subject to poor reproducibility of discovered molecular disease subtypes and can lead to biomarkers that do not generalize [1].”
- Machine Learning and Its Applications to Biology (2007, background): “Because of inadequate validation schemes, many studies published in the literature as successful have been shown to be overoptimistic [40].”
- The cell cycle and cancer (2012, background): “Disappointingly, the actual performance of prediction rules using gene expression has not been as informative as hoped for many tumour types and the list of genes identified can be highly unstable [22,23].”
- A Survey on Filter Techniques for Feature Selection in Gene Expression Microarray Analysis (2012, background): “Several studies conducted for DEGs discovery show that many FS methods are highly dependent on the training set of samples [62], [63] resulting in lists of features which are unstable under variations in the training population.”